Bayer appoints Head of Research and Early Development for Oncology
Bayer have announced that Professor Dominik Ruettinger will be its new Head of Research and Early Development for Oncology, effective 1 October 2021.
List view / Grid view
Bayer have announced that Professor Dominik Ruettinger will be its new Head of Research and Early Development for Oncology, effective 1 October 2021.
2 March 2012 | By Amgen
Tender offer to acquire all outstanding shares of Micromet, Inc. - satisfied...
15 February 2012 | By Amgen
Amgen and Micromet entered into a Merger Agreement...
26 January 2012 | By Amgen
Amgen and Micromet, Inc. announced that the companies have entered into a definitive merger agreement...